臧广喜,杨强,赵永雪,于耀宏,邓意辉
ZANG Guang-xi,YANG Qiang,ZHAO Yong-xue,YU Yao-hong,DENG Yi-hui(School of Pharmacy

• 1:沈阳药科大学药学院

摘要(Abstract)：

目的建立石杉碱甲脂质体(huperzine A liposome,HUPA-L)的制备方法。方法采用pH梯度、硫酸铵[(NH4)2SO4]梯度、乙二胺四乙酸铵(NH4EDTA)梯度方法制备HUPA-L,以阳离子交换树脂分离脂质体和游离药物,HPLC法测定HUPA-L的包封率,并考察温度、孵化时间及药脂比对HUPA-L包封率的影响。体外释放实验研究HUPA-L的释放行为。结果硫酸铵梯度法制备的HU-PA-L包封率最高,包封率随着硫酸铵浓度和温度的升高而增加,随着药脂比的降低而增大,当药物与磷脂质量比小于1∶100时,HUPA-L包封率可达100.0%;HUPA-L体外释放呈现明显的缓释效果。结论硫酸铵梯度法是制备HUPA-L优选方法,硫酸铵的浓度、温度和药脂比是影响包封率的重要因素。
Objective To establish the preparation method of huperzine A liposomes(Huperzine A liposomes,HUPA-L).Methods HUPA-L was prepared with pH gradient,ammonium sulfate[(NH4)2SO4]gradient and NH4EDTA gradient.A cation exchange resin was used to separate the drug and liposomes,the entrapment efficiencies of HUPA-L were determined by HPLC,and the factors that influencing the entrapment efficiencies such as temperature,time and drug-to-lipid ratio were investigated.HUPA-L release behavior was studied by in vitro release experiments.Results The highest entrapment efficiency of HUPA-L was obtained by the gradients of ammonium sulfate method,and it increased with the increase of the concentration of the ammonium sulfate and temperature,and the decrease of drug-to-lipid ratio.When drug-to-lipid ratio was less than 1∶ 100(m∶ m),the entrapment efficiency could reach 100%.The in vitro release of HUPA-L showed a significant sustained-release effect.Conclusions The ammonium sulfate gradient method is an optimal method for preparing HUPA-L,and the concentration of ammonium sulfate,temperature and drug-to-lipid ratio are important factors influencing the entrapment efficiencies.

关键词(KeyWords)： 石杉碱甲;脂质体;硫酸铵梯度法;体外释放
huperzine A;liposome;ammonium sulfate gradient method;in vitro release

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 臧广喜,杨强,赵永雪,于耀宏,邓意辉
ZANG Guang-xi,YANG Qiang,ZHAO Yong-xue,YU Yao-hong,DENG Yi-hui(School of Pharmacy

DOI: 10.14066/j.cnki.cn21-1349/r.2012.03.012

参考文献(References)：

• [1]WANG Rui,YAN Han,TANG Xi-can.Progress in stud-ies of huperzine A,a natural cholinesterase inhibitorfrom Chinese herbal medicine[J].Acta Pharmacol Sin,2006,27(1):1-26.
• [2]尹富敏,杜育阳.血管性痴呆患者石杉碱甲的干预效果分析[J].现代康复,2001,5:74-75.
• [3]ALICIAl R D,JENNIFER J G,KAELEN C D.Role ofHuperzine in the treatment of.Alzheimer's disease[J].Drug Information Rounds,2009,43:514-518.
• [4]夏强,刘群才.石杉碱甲治疗重症肌无力的临床观察[J].实用医药杂志,2002,1(19):31.
• [5]QIAN Bo-chu,WANG Ming,ZHOU Zhi-fang,et al.Pharmacokinetics of tablet huperzine A in six volun-teers[J].Acta Pharmacol Sin,1995,16(5):396.
• [6]PATEL M M,GOYAL B R,BHADADA S V,et al.Get-ting into the brain:approaches to enhance brain drugdelivery[J].CNS Drugs,2009,23(1):35-58.
• [7]王绍宁,邓意辉,严志,等.硫酸氨梯度法制备盐酸环丙沙星脂质体的影响因素[J].沈阳药科大学学报,2003,20(2),93-96.
• [8]杨明,姚志伟,赵毅民,等.HPLC法测定石杉科植物中石杉碱甲的含量[J].军事医学科学院院刊,2000,24(2):123-125.
• [9]孙建绪,翁骏,高永良.高效液相色谱法测定石杉碱甲片的含量[J].解放军药学学报,2002,18(4):231-232.
• [10]赵妍,邓意辉,肖利颖,等.影响主动载药法制备硫酸长春新碱脂质体包封率的因素[J].中国药学杂志,2005,40(20):1717-1720.
• [11]王侨,陈国神.高效液相法测定石杉碱甲在大鼠血浆和脑组织中的浓度[J].中国新药杂志,2009,18(4):369-371,376.
• [12]裘建成,高永良.石杉碱甲缓释片含量和均匀度的HPLC测定[J].中国医药工业杂志,2005,36(11):697-698.
• [13]高萍,徐晖,魏静,等.生物可降解石杉碱甲微球的研究[J].沈阳药科大学学报,2007,24(5):259-262,279.
• [14]赵妍,于彬,邓意辉,等.主动载药法制备硫酸长春新碱脂质体及其包封率测定[J].中国药学杂志,2005,40(20):1559-1562.
• [15]张艳晶,杨强,邓意辉,等.乙二胺四乙酸铵梯度法制备苹果酸舒尼替尼脂质体[J].沈阳药科大学学报.2011,28(5),345-349,374.
• [16]仵文英,黄洁,刘硕,等.苦参碱隐形脂质体的制备及影响因素考察[J].中国医院药学杂志,2008,28(21):1816-1819.
• [17]BALLY M B,HOPE M J,VAN E,et al.Uptake safra-nine and other lipophilic cations into model membranesystems in response to membrane potential[J].BiochimBiophys Acta,1985,812:66-76.
• [18]张彦青,解军波,陈文倩,等.正交试验优选石杉碱甲脂质体的制备研究[J].中草药,2009,40(6):896-898.